Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Vancomycin for MRSA Bacteremia with High Vancomycin MIC
NCT01975662Phase 2Terminated
- Sponsor
- Singapore General Hospital
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daptomycin in Staphylococcus aureus infection, sponsored by Singapore General Hospital. Started Jan 2014; status: terminated.
02
Drugs
daptomycin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT01975662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975662.